Endo Pharmaceuticals has officially withdrawn Opana ER from the market at the FDA’s request. The extended release opioid medication recently became the subject of an inquiry by the agency because of the specific way it was being abused.
Opana ER was designed to slowly and steadily medicate a patient as an extended release medication. However, when crushed, snorted, or injected, an abuser can get the full dose ...
continue reading...
They are some of the strongest painkillers available and were developed for use in only the most extreme of circumstances, yet opioids are prescribed at an alarming rate in the United States. Their use – and misuse – represents a major and growing safety concern and has led many medical professionals to refer to the situation surrounding opioids as an “epidemic” of abuse. The use of such ...
The U.S. Food and Drug Administration (FDA) recently issued a warning about the dangers of accidental exposure to and the improper storage and disposal of fentanyl patches.
Fentanyl is a potent opioid pain reliever and is used to treat patients in constant pain. The patches work by releasing fentanyl into body fats, which slowly releases the drug into the bloodstream over 48 to 72 hours, allowing for long-lasting pain relief. However, because of the potency of the drug, improper ...
continue reading...
